2019 | A global scientific strategy to cure hepatitis B | Revill P.A; Chisari F.V; Block J.M; Dandri M; Gehring A.J; Guo H; Hu J; Kramvis A; Lampertico P; Janssen H.L.A; Levrero M; Li W; Liang T.J; Lim S.-G; Lu F; Penicaud M.C; Tavis J.E; Thimme R; Arbuthnot P; Boonstra A; Chang K.-M; PEI-JER CHEN ; Glebe D; Guidotti L.G; Fellay J; Ferrari C; Jansen L; Lau D.T.Y; Lok A.S; Maini M.K; Mason W; Matthews G; Paraskevis D; Petersen J; Rehermann B; Shin E.-C; Thompson A; van Bömmell F; Wang F.-S; Watashi K; HUNG-CHIH YANG ; Yuan Z; Yuen M.-F; Block T; Miller V; Protzer U; Bréchot C; Locarnini S; Peters M.G; Schinazi R.F; Zoulim F; Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors | The Lancet Gastroenterology and Hepatology | 338 | 282 | |